SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-19-000705
Filing Date
2019-03-11
Accepted
2019-03-11 17:21:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G sc13g07422mer_03112019.htm SC 13G 207755
2 JOINT FILING AGREEMENT ex991to13g07422mer_03112019.htm EX-99.1 11120
  Complete submission text file 0000921895-19-000705.txt   220519
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Subject) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90033 | Film No.: 19673156
SIC: 2834 Pharmaceutical Preparations